However, immune infiltration analysis showed that PRLR expression was feebly correlated with the infiltration level of CD8+ T cells, but not with that of CD4+ T cells, neutrophils, and dendritic cells, indicating that PRLR might affect the prognosis of BC patients but not by regulating the abundance of tumor immune cells. The gene discussed is PRLR; the disease is breast cancer.